- Submissions NOW OPEN
NANS 2027
Call for Abstracts
Shape the future of neuromodulation.
NANS invites physicians, allied health professionals, researchers, engineers and scientific investigators at all career stages to submit abstracts for the NANS 2027 Annual Meeting.
- January 21–24, 2027
- Caesars Palace, Las Vegas
The NANS Annual Meeting showcases the latest scientific discoveries, clinical innovations, and emerging technologies shaping the future of neuromodulation. Accepted abstracts are presented through oral presentations, paper posters, and ePosters.
Separate Call for Late-Breaking Abstracts
A dedicated window for novel, high-impact findings available after the regular deadline. Portal opens October 19 – November 2, 2026.
KEY DATES
Abstract Timeline
JUNE 1, 2026
Regular Abstract Submission Opens
AGUST 17, 2026 · 1:00 PM CDT
Deadline for Regular Abstracts
MID-END OCTOBER 2026
Notifications for Regular Abstracts
OCTOBER 19, 2026
Late-Breaking Submission Opens
NOVEMBER 2, 2026 · 1:00 PM CST
Deadline for Late-Breaking Abstracts
END OF NOVEMBER 2026
Notifications for Late-Breaking Abstracts
JANUARY 4, 2027
Withdrawal & Presenter Change Deadline
JANUARY 11, 2027
ePoster Submission Deadline
JANUARY 21–24, 2027
NANS Annual Meeting · Caesars Palace, Las Vegas
CATEGORIES
Abstract Categories
ALL FORMATS ELIGIBLE
Scientific
Eligible for all presentation formats: Oral Presentation, Paper Poster Presentation, or ePoster.
POSTER FORMATS
Case Reports / Small Series
Eligible for a Paper Poster Presentation or an ePoster.
SCOPE
Topics & Sub-topics
Submitters of Scientific Abstracts and Case Reports/Small Series will select one topic and one sub-topic.
Advocacy and Ethics
- Industry Relationship
- Conflict of Interest
- Education
- Pediatric Neuromodulation
- Diversity
- Other
Basic Science
Brain
- Non-Invasive
- Pain – Headache, DBS for other indication
- Epilepsy
- Movement Disorders
- Psychiatric
- Rehabilitation
- Computer Interface
- New Indications
- CV Drugs
- Other
Advocacy and Ethics
- Headache
- Genitourinary
- GI
- Pain
- Systematic Disorder (RA, etc.)
- Other
Neural Engineering
- Devices (Design and Features)
- Bio Interfaces
- Neuroprosthetics
- Software and Security
- AI
- Newer Technologies
- Other
Socioeconomics
- Practice Management (reimburse-build)
- Malpractice
- Access
- Contract Negotiation
- Other
Spine
- Pain
- IDDS
- Spasticity
- Cardiovascular
- Restoration
- New Indication (Parkinson’s Disease)
- Other
Other
PRESENTATION
Presentation Formats
POLICIES
Submission Policies
Submission Guidelines & Instructions
Please review the full submission guidelines and the step-by-step screenshot instructions prior to submitting your abstract.
Duplicate Abstracts
Each abstract may be submitted only once and to one category. Ensure all authors agree on a single submitter. Duplicate abstracts will result in automatic rejection of all entries.
Original Research
Abstracts must be based on original research and must not have been previously submitted or published in the same form elsewhere.
If similar data has been presented elsewhere, the submission must include new or updated content — at least one aspect must be new and not publicly disseminated.
Questions can be directed to Kim Stamp at kstamp@neuromodulation.org.
Review Process
All submissions undergo a blinded peer-review process conducted by independent scientific reviewers. Abstracts are evaluated on scientific merit, originality, and relevance to neuromodulation. Final presentation format is at the discretion of the Scientific Program Committee Chairs/Abstract Chairs.
Meeting Expenses
All accepted abstract presenters — including ePoster-only presenters — are responsible for their own meeting registration, travel, housing, and poster printing (if selected for the Paper Poster Session).
Withdrawal of Accepted Abstracts
Requests must be submitted in writing by the Presenting Author to kstamp@neuromodulation.org, including the abstract title and Submission ID. Withdrawal deadline: Monday, January 4, 2027. If the Presenting Author does not confirm participation by the deadline, the abstract is considered withdrawn.
Changing the Presenting Author
Contact kstamp@neuromodulation.org to request a change. For Oral abstracts, the new Presenting Author must comply with ACCME standards. Deadline: Monday, January 4, 2027; changes will not be accepted after this date.
Abstract Publication & Release
Abstract titles and author names will be published in the NANS 2027 online program. Full abstract content will be available in the NANS 2027 meeting app upon launch. Media inquiries should be directed to Jessie Schlacks at jschlacks@neuromodulation.org.
Questions about Abstracts?
Contact our Education Coordinator, Kim Stamp, for help with submissions, withdrawals, or presenter changes.